Guangzhou Improve Med Instrument (300030) - Total Liabilities

Latest as of March 2026: CN¥346.01 Million CNY ≈ $50.63 Million USD

Based on the latest financial reports, Guangzhou Improve Med Instrument (300030) has total liabilities worth CN¥346.01 Million CNY (≈ $50.63 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Guangzhou Improve Med Instrument to see how much of total assets are deployed in long-term investments.

Guangzhou Improve Med Instrument - Total Liabilities Trend (2006–2025)

This chart illustrates how Guangzhou Improve Med Instrument's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Guangzhou Improve Med Instrument asset portfolio.

Guangzhou Improve Med Instrument Competitors by Total Liabilities

The table below lists competitors of Guangzhou Improve Med Instrument ranked by their total liabilities.

Company Country Total Liabilities
UD Electronic
TWO:3689
Taiwan NT$1.93 Billion
Antibiotice Ia
RO:ATB
Romania RON623.78 Million
Wholetech System Hitech Ltd
TWO:3402
Taiwan NT$4.06 Billion
Prudential plc
LSE:PRU
UK GBX190.90 Billion
Vinacafe Bien Hoa JSC
VN:VCF
Vietnam ₫588.19 Billion
Fortress Value Acquisition Corp. V Class A Ordinary Shares
NASDAQ:FVAV
USA $17.18 Million
Seah Steel Corp
KO:003030
Korea ₩3.62 Trillion
Zhejiang Benli Technology Co. Ltd.
SHE:301065
China CN¥241.20 Million

Liability Composition Analysis (2006–2025)

This chart breaks down Guangzhou Improve Med Instrument's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Guangzhou Improve Med Instrument to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.46 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.54 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.34 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guangzhou Improve Med Instrument's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guangzhou Improve Med Instrument (2006–2025)

The table below shows the annual total liabilities of Guangzhou Improve Med Instrument from 2006 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥371.82 Million
≈ $54.41 Million
-38.06%
2024-12-31 CN¥600.28 Million
≈ $87.84 Million
-9.55%
2023-12-31 CN¥663.63 Million
≈ $97.11 Million
-10.03%
2022-12-31 CN¥737.57 Million
≈ $107.93 Million
-7.18%
2021-12-31 CN¥794.63 Million
≈ $116.28 Million
+7.10%
2020-12-31 CN¥741.94 Million
≈ $108.57 Million
+10.98%
2019-12-31 CN¥668.54 Million
≈ $97.83 Million
-3.90%
2018-12-31 CN¥695.67 Million
≈ $101.80 Million
-11.06%
2017-12-31 CN¥782.15 Million
≈ $114.45 Million
+51.67%
2016-12-31 CN¥515.70 Million
≈ $75.46 Million
+1.34%
2015-12-31 CN¥508.88 Million
≈ $74.46 Million
+114.42%
2014-12-31 CN¥237.33 Million
≈ $34.73 Million
+115.02%
2013-12-31 CN¥110.38 Million
≈ $16.15 Million
+40.42%
2012-12-31 CN¥78.60 Million
≈ $11.50 Million
+14.80%
2011-12-31 CN¥68.47 Million
≈ $10.02 Million
+16.66%
2010-12-31 CN¥58.69 Million
≈ $8.59 Million
-37.77%
2009-12-31 CN¥94.31 Million
≈ $13.80 Million
+49.80%
2008-12-31 CN¥62.96 Million
≈ $9.21 Million
+303.20%
2007-12-31 CN¥15.61 Million
≈ $2.28 Million
-24.27%
2006-12-31 CN¥20.62 Million
≈ $3.02 Million
--

About Guangzhou Improve Med Instrument

SHE:300030 China Medical Instruments & Supplies
Market Cap
$296.80 Million
CN¥2.03 Billion CNY
Market Cap Rank
#14995 Global
#4464 in China
Share Price
CN¥6.56
Change (1 day)
+0.00%
52-Week Range
CN¥5.80 - CN¥8.60
All Time High
CN¥22.76
About

Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising feces and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company… Read more